Furthermore, it has been shown that AA exerts an anti-convulsion activity at a dose of 250 mg/kg, i.p. administered in rats via activation of the GABAB1R/CaMKII/CREB pathway, which suggests that AA has therapeutic potential in epilepsy [75]. This evidence concerns the gene CAMK2G and epilepsy.